EP Patent

EP3999514A1 — Crystalline lorlatinib : fumaric acid and solid state form thereof

Assigned to Tapi Croatia Industries Ltd · Expires 2022-05-25 · 4y expired

What this patent protects

The present disclosure relates to crystalline Lorlatinib : Fumaric acid, solid state forms thereof, processes for preparation thereof, pharmaceutical compositions and methods of use thereof.

USPTO Abstract

The present disclosure relates to crystalline Lorlatinib : Fumaric acid, solid state forms thereof, processes for preparation thereof, pharmaceutical compositions and methods of use thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP3999514A1
Jurisdiction
EP
Classification
—
Expires
2022-05-25
Drug substance claim
No
Drug product claim
No
Assignee
Tapi Croatia Industries Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.